These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20182709)

  • 1. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
    Monti DM; Guglielmi F; Monti M; Cozzolino F; Torrassa S; Relini A; Pucci P; Arciello A; Piccoli R
    Eur Biophys J; 2010 Aug; 39(9):1289-99. PubMed ID: 20182709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
    Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I.
    Mizuguchi C; Nakamura M; Kurimitsu N; Ohgita T; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
    Sci Rep; 2018 Apr; 8(1):5497. PubMed ID: 29615818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential.
    Di Gaetano S; Guglielmi F; Arciello A; Mangione P; Monti M; Pagnozzi D; Raimondi S; Giorgetti S; Orrù S; Canale C; Pucci P; Dobson CM; Bellotti V; Piccoli R
    Biochem Biophys Res Commun; 2006 Dec; 351(1):223-8. PubMed ID: 17056013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
    Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
    J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N-terminal fragment of apoA-I.
    Kurimitsu N; Mizuguchi C; Fujita K; Taguchi S; Ohgita T; Nishitsuji K; Shimanouchi T; Saito H
    FEBS Lett; 2020 May; 594(9):1443-1452. PubMed ID: 31968125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I.
    Andreola A; Bellotti V; Giorgetti S; Mangione P; Obici L; Stoppini M; Torres J; Monzani E; Merlini G; Sunde M
    J Biol Chem; 2003 Jan; 278(4):2444-51. PubMed ID: 12421824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
    Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
    Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I.
    Mikawa S; Mizuguchi C; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Sakashita N; Otaka A; Akaji K; Saito H
    FEBS Lett; 2016 Oct; 590(20):3492-3500. PubMed ID: 27654470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
    Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
    FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes.
    Rusciano G; Pesce G; Zito G; Sasso A; Gaglione R; Del Giudice R; Piccoli R; Monti DM; Arciello A
    Biochim Biophys Acta; 2016 Apr; 1860(4):795-801. PubMed ID: 26820473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Aggregation of Apolipoprotein A-I.
    Frankel R; Sparr E; Linse S
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.
    Arciello A; De Marco N; Del Giudice R; Guglielmi F; Pucci P; Relini A; Monti DM; Piccoli R
    J Cell Mol Med; 2011 Dec; 15(12):2652-63. PubMed ID: 21306558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
    Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
    J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
    Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.